02/18/2020
6:00 AM | Akebia Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/06/2020
12:05 PM | Akebia Therapeutics (Filer)
| Form CT ORDER
| |
11/22/2019
5:20 AM | Akebia Therapeutics (Issuer)
GILMAN STEVEN C (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/22/2019
5:20 AM | Akebia Therapeutics (Issuer)
Smith Cynthia (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/22/2019
5:19 AM | Akebia Therapeutics (Issuer)
Burke Steven Keith (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/21/2019
5:32 AM | Akebia Therapeutics (Issuer)
Butler John P. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/21/2019
5:31 AM | ADAMS ADRIAN (Reporting)
Akebia Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/12/2019
4:31 PM | Akebia Therapeutics (Filer)
| Form 424B5
| |
11/12/2019
4:20 PM | Akebia Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/12/2019
3:31 PM | Akebia Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/12/2019
7:59 AM | Akebia Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/17/2019
11:52 AM | Akebia Therapeutics (Filer)
| Form CT ORDER
| |
09/11/2019
3:15 PM | Akebia Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/04/2019
3:03 PM | Akebia Therapeutics (Issuer)
Burke Steven Keith (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/08/2019
3:48 PM | Akebia Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
08/08/2019
7:22 AM | Akebia Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/05/2019
3:04 PM | Akebia Therapeutics (Issuer)
Burke Steven Keith (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
06/11/2019
3:10 PM | Akebia Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/10/2019
3:04 PM | Akebia Therapeutics (Issuer)
Smith Cynthia (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/10/2019
3:04 PM | Akebia Therapeutics (Issuer)
ROGERS MICHAEL W (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/10/2019
3:04 PM | Akebia Therapeutics (Issuer)
Morrison Jodie Pope (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/10/2019
3:04 PM | Akebia Therapeutics (Issuer)
Heffernan Michael Thomas (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/10/2019
3:04 PM | Akebia Therapeutics (Issuer)
GOWEN MAXINE (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/10/2019
3:04 PM | Akebia Therapeutics (Issuer)
GILMAN STEVEN C (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/10/2019
3:04 PM | Akebia Therapeutics (Issuer)
Enyedy Mark J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/10/2019
3:03 PM | Akebia Therapeutics (Issuer)
Canute Scott A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/10/2019
3:03 PM | ADAMS ADRIAN (Reporting)
Akebia Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/05/2019
3:05 PM | Akebia Therapeutics (Issuer)
Butler John P. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/04/2019
6:00 AM | Akebia Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/09/2019
3:07 PM | Akebia Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/09/2019
3:02 PM | Akebia Therapeutics (Issuer)
Faulkingham Dell (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
05/09/2019
7:18 AM | Akebia Therapeutics (Filer)
| Form DEFA14A
| |
05/09/2019
7:16 AM | Akebia Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/26/2019
3:05 PM | Akebia Therapeutics (Filer)
| Form DEF 14A
| |
04/18/2019
6:50 AM | Akebia Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/12/2019
3:01 PM | Akebia Therapeutics (Issuer)
Jain Rita (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/12/2019
3:01 PM | Akebia Therapeutics (Issuer)
Dahan Michel (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/12/2019
3:00 PM | Akebia Therapeutics (Issuer)
Hadas Nicole R. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/12/2019
3:00 PM | Akebia Therapeutics (Issuer)
Tubridy Karen L (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/12/2019
3:00 PM | Akebia Therapeutics (Issuer)
Amello Jason (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/10/2019
6:35 AM | Akebia Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/26/2019
3:07 PM | Akebia Therapeutics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
03/19/2019
5:02 AM | Akebia Therapeutics (Filer)
| Form NT 10-K
| |
03/18/2019
3:05 PM | Akebia Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/05/2019
3:05 PM | Akebia Therapeutics (Issuer)
Butler John P. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/14/2019
3:30 PM | ABRAMS CAPITAL MANAGEMENT, L.P. (Filed by)
Akebia Therapeutics (Subject)
| Form SC 13G/A
| |
01/25/2019
3:13 PM | Akebia Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
01/11/2019
4:05 PM | Akebia Therapeutics (Subject)
Satter Muneer A (Filed by)
| Form SC 13D/A
| |
01/10/2019
4:05 PM | Akebia Therapeutics (Subject)
BlackRock Inc. (Filed by)
| Form SC 13G/A
| |
01/09/2019
3:22 PM | Akebia Therapeutics (Subject)
BAUPOST GROUP LLC/MA (Filed by)
| Form SC 13G
| |
01/07/2019
2:05 PM | Akebia Therapeutics (Subject)
Novo Holdings A/S (Filed by)
| Form SC 13G/A
| |
01/07/2019
6:53 AM | Akebia Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/21/2018
3:34 PM | Akebia Therapeutics (Subject)
Nantahala Capital Management, LLC (Filed by)
| Form SC 13D/A
| |
12/20/2018
5:06 AM | Akebia Therapeutics (Filer)
| Form 8-K/A
| |
12/13/2018
5:44 PM | Akebia Therapeutics (Issuer)
Morrison Jodie Pope (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/13/2018
5:44 PM | Akebia Therapeutics (Issuer)
ROGERS MICHAEL W (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/13/2018
5:40 PM | Akebia Therapeutics (Issuer)
GILMAN STEVEN C (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/13/2018
5:39 PM | Akebia Therapeutics (Issuer)
Enyedy Mark J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/13/2018
5:39 PM | ADAMS ADRIAN (Reporting)
Akebia Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/13/2018
5:38 PM | Akebia Therapeutics (Issuer)
Heffernan Michael Thomas (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/13/2018
5:32 PM | Akebia Therapeutics (Issuer)
Morrison Jodie Pope (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
12/13/2018
5:31 PM | Akebia Therapeutics (Issuer)
ROGERS MICHAEL W (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
12/13/2018
5:30 PM | ADAMS ADRIAN (Reporting)
Akebia Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
12/13/2018
5:28 PM | Akebia Therapeutics (Issuer)
Heffernan Michael Thomas (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
12/13/2018
5:27 PM | Akebia Therapeutics (Issuer)
GILMAN STEVEN C (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
12/13/2018
5:26 PM | Akebia Therapeutics (Issuer)
Enyedy Mark J (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
12/13/2018
8:19 AM | Akebia Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
12/13/2018
7:18 AM | Akebia Therapeutics (Issuer)
Tubridy Karen L (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/13/2018
7:17 AM | Akebia Therapeutics (Issuer)
Jain Rita (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/13/2018
7:15 AM | Akebia Therapeutics (Issuer)
Hadas Nicole R. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/13/2018
7:14 AM | Akebia Therapeutics (Issuer)
Dahan Michel (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/13/2018
7:10 AM | Akebia Therapeutics (Issuer)
Butler John P. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/13/2018
7:08 AM | Akebia Therapeutics (Issuer)
Amello Jason (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/13/2018
6:16 AM | Akebia Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/07/2018
4:22 PM | ABRAMS CAPITAL MANAGEMENT, L.P. (Filed by)
Akebia Therapeutics (Subject)
| Form SC 13G
| |
11/30/2018
8:00 AM | Akebia Therapeutics (Filed by)
KERYX BIOPHARMACEUTICALS INC (Subject)
| Form 425
| |
11/29/2018
6:03 AM | Akebia Therapeutics (Filed by)
KERYX BIOPHARMACEUTICALS INC (Subject)
| Form 425
| |
11/16/2018
5:10 AM | Akebia Therapeutics (Filed by)
KERYX BIOPHARMACEUTICALS INC (Subject)
| Form 425
| |
11/16/2018
5:10 AM | Akebia Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/16/2018
5:08 AM | Akebia Therapeutics (Filed by)
KERYX BIOPHARMACEUTICALS INC (Subject)
| Form 425
| |
11/15/2018
4:18 PM | Akebia Therapeutics (Filed by)
KERYX BIOPHARMACEUTICALS INC (Subject)
| Form 425
| |
11/13/2018
3:06 PM | Akebia Therapeutics (Filed by)
KERYX BIOPHARMACEUTICALS INC (Subject)
| Form 425
| |
11/13/2018
3:06 PM | Akebia Therapeutics (Filed by)
KERYX BIOPHARMACEUTICALS INC (Subject)
| Form 425
| |
11/08/2018
3:35 PM | Akebia Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
10/30/2018
11:15 PM | Akebia Therapeutics (Filer)
| Form EFFECT
| |
10/30/2018
4:29 PM | Akebia Therapeutics (Filed by)
KERYX BIOPHARMACEUTICALS INC (Subject)
| Form 425
| |
10/30/2018
4:23 PM | Akebia Therapeutics (Filer)
| Form 424B3
| |
10/29/2018
4:27 PM | Akebia Therapeutics (Filed by)
KERYX BIOPHARMACEUTICALS INC (Subject)
| Form 425
| |
10/29/2018
7:09 AM | Akebia Therapeutics (Filer)
| Form S-4/A
| |
10/25/2018
4:18 PM | Akebia Therapeutics (Filer)
| Form S-4/A
| |
10/02/2018
7:00 AM | Akebia Therapeutics (Filed by)
KERYX BIOPHARMACEUTICALS INC (Subject)
| Form 425
| |
09/30/2018
11:00 PM | Akebia Therapeutics (Filed by)
KERYX BIOPHARMACEUTICALS INC (Subject)
| Form 425
| |
09/30/2018
11:00 PM | Akebia Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/30/2018
11:00 PM | Akebia Therapeutics (Filer)
| Form S-4
Registration statement under Securities Act of 1933 | |
09/26/2018
3:03 PM | Akebia Therapeutics (Subject)
Nantahala Capital Management, LLC (Filed by)
| Form SC 13D
| |
09/14/2018
6:30 AM | Akebia Therapeutics (Filed by)
KERYX BIOPHARMACEUTICALS INC (Subject)
| Form 425
| |
09/06/2018
7:31 AM | Akebia Therapeutics (Filed by)
KERYX BIOPHARMACEUTICALS INC (Subject)
| Form 425
| |
08/31/2018
11:02 AM | Akebia Therapeutics (Subject)
EAGLE ASSET MANAGEMENT INC (Filed by)
| Form SC 13G/A
| |
08/29/2018
3:02 PM | Akebia Therapeutics (Issuer)
Smith Cynthia (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/29/2018
3:01 PM | Akebia Therapeutics (Issuer)
Smith Cynthia (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
